What is Needed to Properly Address Diseases of Brain Aging
Everything you need to know about somatic mutations in Parkinson’s disease.
on the Advantages of Being a Physician-Scientist, Pharmacogenomics, Biomarker Studies, and more
What would you do with $1,000,000,000 for PD?
Incremental Change or A New Approach?
The Start of a Bold New Initiative
on Autophagy as a Therapeutic Target in Neurodegenerative Diseases
Engaging Patients in Therapeutic Development
Nudging Stakeholder Interests a Little Closer Together
43 Experts Weigh in on the Most Promising Disease-Modifying Therapies in PD